NCT00748046 Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton Status COMPLETED Phase PHASE1
NCT00569036 Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00537823 Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement Status TERMINATED Phase PHASE2
NCT00446446 PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) Status COMPLETED Phase PHASE2
NCT00320320 Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00313872 Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer Status COMPLETED Phase PHASE3
NCT00305188 Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy. Status COMPLETED Phase PHASE3
NCT00272051 XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy Status COMPLETED Phase PHASE3
NCT00265200 Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer Status TERMINATED Phase PHASE2
NCT00113763 Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00107861 Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases Status COMPLETED Phase PHASE1/PHASE2
NCT00102024 Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT00100685 Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) Status TERMINATED Phase PHASE2
NCT00099970 Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy Status COMPLETED Phase PHASE2
NCT00099281 DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer Status TERMINATED Phase PHASE3
NCT00097487 A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane Status COMPLETED Phase N/A
NCT00096967 A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study Status COMPLETED Phase PHASE3
NCT00095108 Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer Status COMPLETED Phase PHASE1